Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus.
Saved in:
| Title: | Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus. |
|---|---|
| Authors: | Bodei L; Memorial Sloan Kettering Cancer Center, New York, New York bodeil@mskcc.org., Herrmann K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany., Baum RP; Theranostics Center for Molecular Radiotherapy and Imaging, Zentralklinik Bad Berka, Bad Berka, Germany., Kidd M; Wren Laboratories, Branford, Connecticut., Malczewska A; Department of Endocrinology and Neuroendocrine Tumors, Medical University of Silesia, Katowice, Poland; and., Modlin IM; Yale School of Medicine, Department of Surgery, New Haven, Connecticut. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Jan; Vol. 60 (1), pp. 7-8. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.118.219386 |
